Summary
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
According to APO Research, The global Peanut Allergy Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Peanut Allergy Therapeutics include Mylan, Bayer, UCB Pharma, J & J, Perrigo, GSK, Kaleo, Amneal Pharma and ALK Abello, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Peanut Allergy Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Peanut Allergy Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Peanut Allergy Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peanut Allergy Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Peanut Allergy Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peanut Allergy Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Peanut Allergy Therapeutics segment by Company
Mylan
Bayer
UCB Pharma
J & J
Perrigo
GSK
Kaleo
Amneal Pharma
ALK Abello
Aimmune Therapeutics
HUAPONT Pharm
Allergy Therapeutics
ASIT Biotech
Sanofi
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Peanut Allergy Therapeutics segment by Type
Epinephrine Injection
Antihistamines
Oral Immunotherapy
Other
Peanut Allergy Therapeutics segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Peanut Allergy Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Peanut Allergy Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peanut Allergy Therapeutics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Peanut Allergy Therapeutics Market by Type
1.2.1 Global Peanut Allergy Therapeutics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Oral Immunotherapy
1.2.5 Other
1.3 Peanut Allergy Therapeutics Market by Distribution Channel
1.3.1 Global Peanut Allergy Therapeutics Market Size by Distribution Channel, 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Peanut Allergy Therapeutics Market Dynamics
2.1 Peanut Allergy Therapeutics Industry Trends
2.2 Peanut Allergy Therapeutics Industry Drivers
2.3 Peanut Allergy Therapeutics Industry Opportunities and Challenges
2.4 Peanut Allergy Therapeutics Industry Restraints
3 Global Growth Perspective
3.1 Global Peanut Allergy Therapeutics Market Perspective (2019-2030)
3.2 Global Peanut Allergy Therapeutics Growth Trends by Region
3.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Peanut Allergy Therapeutics Market Size by Region (2019-2024)
3.2.3 Global Peanut Allergy Therapeutics Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Peanut Allergy Therapeutics Revenue by Players
4.1.1 Global Peanut Allergy Therapeutics Revenue by Players (2019-2024)
4.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2019-2024)
4.1.3 Global Peanut Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Peanut Allergy Therapeutics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Peanut Allergy Therapeutics Key Players Headquarters & Area Served
4.4 Global Peanut Allergy Therapeutics Players, Product Type & Application
4.5 Global Peanut Allergy Therapeutics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Peanut Allergy Therapeutics Market CR5 and HHI
4.6.2 Global Top 5 and 10 Peanut Allergy Therapeutics Players Market Share by Revenue in 2023
4.6.3 2023 Peanut Allergy Therapeutics Tier 1, Tier 2, and Tier 3
5 Peanut Allergy Therapeutics Market Size by Type
5.1 Global Peanut Allergy Therapeutics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Peanut Allergy Therapeutics Revenue by Type (2019-2030)
5.3 Global Peanut Allergy Therapeutics Revenue Market Share by Type (2019-2030)
6 Peanut Allergy Therapeutics Market Size by Application
6.1 Global Peanut Allergy Therapeutics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Peanut Allergy Therapeutics Revenue by Application (2019-2030)
6.3 Global Peanut Allergy Therapeutics Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Mylan
7.1.1 Mylan Comapny Information
7.1.2 Mylan Business Overview
7.1.3 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.1.4 Mylan Peanut Allergy Therapeutics Product Portfolio
7.1.5 Mylan Recent Developments
7.2 Bayer
7.2.1 Bayer Comapny Information
7.2.2 Bayer Business Overview
7.2.3 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.2.4 Bayer Peanut Allergy Therapeutics Product Portfolio
7.2.5 Bayer Recent Developments
7.3 UCB Pharma
7.3.1 UCB Pharma Comapny Information
7.3.2 UCB Pharma Business Overview
7.3.3 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.3.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
7.3.5 UCB Pharma Recent Developments
7.4 J & J
7.4.1 J & J Comapny Information
7.4.2 J & J Business Overview
7.4.3 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.4.4 J & J Peanut Allergy Therapeutics Product Portfolio
7.4.5 J & J Recent Developments
7.5 Perrigo
7.5.1 Perrigo Comapny Information
7.5.2 Perrigo Business Overview
7.5.3 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.5.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
7.5.5 Perrigo Recent Developments
7.6 GSK
7.6.1 GSK Comapny Information
7.6.2 GSK Business Overview
7.6.3 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.6.4 GSK Peanut Allergy Therapeutics Product Portfolio
7.6.5 GSK Recent Developments
7.7 Kaleo
7.7.1 Kaleo Comapny Information
7.7.2 Kaleo Business Overview
7.7.3 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.7.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
7.7.5 Kaleo Recent Developments
7.8 Amneal Pharma
7.8.1 Amneal Pharma Comapny Information
7.8.2 Amneal Pharma Business Overview
7.8.3 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.8.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
7.8.5 Amneal Pharma Recent Developments
7.9 ALK Abello
7.9.1 ALK Abello Comapny Information
7.9.2 ALK Abello Business Overview
7.9.3 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.9.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
7.9.5 ALK Abello Recent Developments
7.10 Aimmune Therapeutics
7.10.1 Aimmune Therapeutics Comapny Information
7.10.2 Aimmune Therapeutics Business Overview
7.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.10.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
7.10.5 Aimmune Therapeutics Recent Developments
7.11 HUAPONT Pharm
7.11.1 HUAPONT Pharm Comapny Information
7.11.2 HUAPONT Pharm Business Overview
7.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.11.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
7.11.5 HUAPONT Pharm Recent Developments
7.12 Allergy Therapeutics
7.12.1 Allergy Therapeutics Comapny Information
7.12.2 Allergy Therapeutics Business Overview
7.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.12.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
7.12.5 Allergy Therapeutics Recent Developments
7.13 ASIT Biotech
7.13.1 ASIT Biotech Comapny Information
7.13.2 ASIT Biotech Business Overview
7.13.3 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.13.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
7.13.5 ASIT Biotech Recent Developments
7.14 Sanofi
7.14.1 Sanofi Comapny Information
7.14.2 Sanofi Business Overview
7.14.3 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.14.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
7.14.5 Sanofi Recent Developments
7.15 DBV Technologies
7.15.1 DBV Technologies Comapny Information
7.15.2 DBV Technologies Business Overview
7.15.3 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.15.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
7.15.5 DBV Technologies Recent Developments
7.16 HAL Allergy
7.16.1 HAL Allergy Comapny Information
7.16.2 HAL Allergy Business Overview
7.16.3 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.16.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
7.16.5 HAL Allergy Recent Developments
7.17 Intrommune Therapeutics
7.17.1 Intrommune Therapeutics Comapny Information
7.17.2 Intrommune Therapeutics Business Overview
7.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2019-2024)
7.17.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
7.17.5 Intrommune Therapeutics Recent Developments
8 North America
8.1 North America Peanut Allergy Therapeutics Revenue (2019-2030)
8.2 North America Peanut Allergy Therapeutics Revenue by Type (2019-2030)
8.2.1 North America Peanut Allergy Therapeutics Revenue by Type (2019-2024)
8.2.2 North America Peanut Allergy Therapeutics Revenue by Type (2025-2030)
8.3 North America Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
8.4 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2030)
8.4.1 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024)
8.4.2 North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2025-2030)
8.5 North America Peanut Allergy Therapeutics Revenue Share by Distribution Channel (2019-2030)
8.6 North America Peanut Allergy Therapeutics Revenue by Country
8.6.1 North America Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Peanut Allergy Therapeutics Revenue by Country (2019-2024)
8.6.3 North America Peanut Allergy Therapeutics Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Peanut Allergy Therapeutics Revenue (2019-2030)
9.2 Europe Peanut Allergy Therapeutics Revenue by Type (2019-2030)
9.2.1 Europe Peanut Allergy Therapeutics Revenue by Type (2019-2024)
9.2.2 Europe Peanut Allergy Therapeutics Revenue by Type (2025-2030)
9.3 Europe Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
9.4 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2030)
9.4.1 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024)
9.4.2 Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2025-2030)
9.5 Europe Peanut Allergy Therapeutics Revenue Share by Distribution Channel (2019-2030)
9.6 Europe Peanut Allergy Therapeutics Revenue by Country
9.6.1 Europe Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Peanut Allergy Therapeutics Revenue by Country (2019-2024)
9.6.3 Europe Peanut Allergy Therapeutics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Peanut Allergy Therapeutics Revenue (2019-2030)
10.2 China Peanut Allergy Therapeutics Revenue by Type (2019-2030)
10.2.1 China Peanut Allergy Therapeutics Revenue by Type (2019-2024)
10.2.2 China Peanut Allergy Therapeutics Revenue by Type (2025-2030)
10.3 China Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
10.4 China Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2030)
10.4.1 China Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024)
10.4.2 China Peanut Allergy Therapeutics Revenue by Distribution Channel (2025-2030)
10.5 China Peanut Allergy Therapeutics Revenue Share by Distribution Channel (2019-2030)
11 Asia (Excluding China)
11.1 Asia Peanut Allergy Therapeutics Revenue (2019-2030)
11.2 Asia Peanut Allergy Therapeutics Revenue by Type (2019-2030)
11.2.1 Asia Peanut Allergy Therapeutics Revenue by Type (2019-2024)
11.2.2 Asia Peanut Allergy Therapeutics Revenue by Type (2025-2030)
11.3 Asia Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
11.4 Asia Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2030)
11.4.1 Asia Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024)
11.4.2 Asia Peanut Allergy Therapeutics Revenue by Distribution Channel (2025-2030)
11.5 Asia Peanut Allergy Therapeutics Revenue Share by Distribution Channel (2019-2030)
11.6 Asia Peanut Allergy Therapeutics Revenue by Country
11.6.1 Asia Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Peanut Allergy Therapeutics Revenue by Country (2019-2024)
11.6.3 Asia Peanut Allergy Therapeutics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Peanut Allergy Therapeutics Revenue (2019-2030)
12.2 MEALA Peanut Allergy Therapeutics Revenue by Type (2019-2030)
12.2.1 MEALA Peanut Allergy Therapeutics Revenue by Type (2019-2024)
12.2.2 MEALA Peanut Allergy Therapeutics Revenue by Type (2025-2030)
12.3 MEALA Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
12.4 MEALA Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2030)
12.4.1 MEALA Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024)
12.4.2 MEALA Peanut Allergy Therapeutics Revenue by Distribution Channel (2025-2030)
12.5 MEALA Peanut Allergy Therapeutics Revenue Share by Distribution Channel (2019-2030)
12.6 MEALA Peanut Allergy Therapeutics Revenue by Country
12.6.1 MEALA Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Peanut Allergy Therapeutics Revenue by Country (2019-2024)
12.6.3 MEALA Peanut Allergy Therapeutics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Epinephrine Injection Major Manufacturers
Table 2. Antihistamines Major Manufacturers
Table 3. Oral Immunotherapy Major Manufacturers
Table 4. Other Major Manufacturers
Table 5. Global Peanut Allergy Therapeutics Market Size Growth Rate by Distribution Channel (US$ Million), 2019 VS 2023 VS 2030
Table 6. Hospital Pharmacy Major Manufacturers
Table 7. Retail Pharmacy Major Manufacturers
Table 8. Other Major Manufacturers
Table 9. Peanut Allergy Therapeutics Industry Trends
Table 10. Peanut Allergy Therapeutics Industry Drivers
Table 11. Peanut Allergy Therapeutics Industry Opportunities and Challenges
Table 12. Peanut Allergy Therapeutics Industry Restraints
Table 13. Global Peanut Allergy Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Peanut Allergy Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Peanut Allergy Therapeutics Market Share by Region (2019-2024)
Table 16. Global Peanut Allergy Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Peanut Allergy Therapeutics Market Share by Region (2025-2030)
Table 18. Global Peanut Allergy Therapeutics Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Peanut Allergy Therapeutics Revenue Market Share by Players (2019-2024)
Table 20. Global Peanut Allergy Therapeutics Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Peanut Allergy Therapeutics Key Players Headquarters & Area Served
Table 22. Global Peanut Allergy Therapeutics Players, Product Type & Application
Table 23. Global Peanut Allergy Therapeutics Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Peanut Allergy Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Peanut Allergy Therapeutics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Peanut Allergy Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Peanut Allergy Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Peanut Allergy Therapeutics Revenue by Distribution Channel 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024) & (US$ Million)
Table 33. Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2025-2030) & (US$ Million)
Table 34. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2019-2024) & (US$ Million)
Table 35. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2025-2030) & (US$ Million)
Table 36. Mylan Company Information
Table 37. Mylan Business Overview
Table 38. Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. Mylan Peanut Allergy Therapeutics Product Portfolio
Table 40. Mylan Recent Development
Table 41. Bayer Company Information
Table 42. Bayer Business Overview
Table 43. Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Bayer Peanut Allergy Therapeutics Product Portfolio
Table 45. Bayer Recent Development
Table 46. UCB Pharma Company Information
Table 47. UCB Pharma Business Overview
Table 48. UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. UCB Pharma Peanut Allergy Therapeutics Product Portfolio
Table 50. UCB Pharma Recent Development
Table 51. J & J Company Information
Table 52. J & J Business Overview
Table 53. J & J Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. J & J Peanut Allergy Therapeutics Product Portfolio
Table 55. J & J Recent Development
Table 56. Perrigo Company Information
Table 57. Perrigo Business Overview
Table 58. Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Perrigo Peanut Allergy Therapeutics Product Portfolio
Table 60. Perrigo Recent Development
Table 61. GSK Company Information
Table 62. GSK Business Overview
Table 63. GSK Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. GSK Peanut Allergy Therapeutics Product Portfolio
Table 65. GSK Recent Development
Table 66. Kaleo Company Information
Table 67. Kaleo Business Overview
Table 68. Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Kaleo Peanut Allergy Therapeutics Product Portfolio
Table 70. Kaleo Recent Development
Table 71. Amneal Pharma Company Information
Table 72. Amneal Pharma Business Overview
Table 73. Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
Table 75. Amneal Pharma Recent Development
Table 76. ALK Abello Company Information
Table 77. ALK Abello Business Overview
Table 78. ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. ALK Abello Peanut Allergy Therapeutics Product Portfolio
Table 80. ALK Abello Recent Development
Table 81. Aimmune Therapeutics Company Information
Table 82. Aimmune Therapeutics Business Overview
Table 83. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
Table 85. Aimmune Therapeutics Recent Development
Table 86. HUAPONT Pharm Company Information
Table 87. HUAPONT Pharm Business Overview
Table 88. HUAPONT Pharm Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 89. HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
Table 90. HUAPONT Pharm Recent Development
Table 91. Allergy Therapeutics Company Information
Table 92. Allergy Therapeutics Business Overview
Table 93. Allergy Therapeutics Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 94. Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
Table 95. Allergy Therapeutics Recent Development
Table 96. ASIT Biotech Company Information
Table 97. ASIT Biotech Business Overview
Table 98. ASIT Biotech Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 99. ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
Table 100. ASIT Biotech Recent Development
Table 101. Sanofi Company Information
Table 102. Sanofi Business Overview
Table 103. Sanofi Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 104. Sanofi Peanut Allergy Therapeutics Product Portfolio
Table 105. Sanofi Recent Development
Table 106. DBV Technologies Company Information
Table 107. DBV Technologies Business Overview
Table 108. DBV Technologies Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 109. DBV Technologies Peanut Allergy Therapeutics Product Portfolio
Table 110. DBV Technologies Recent Development
Table 111. HAL Allergy Company Information
Table 112. HAL Allergy Business Overview
Table 113. HAL Allergy Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 114. HAL Allergy Peanut Allergy Therapeutics Product Portfolio
Table 115. HAL Allergy Recent Development
Table 116. Intrommune Therapeutics Company Information
Table 117. Intrommune Therapeutics Business Overview
Table 118. Intrommune Therapeutics Peanut Allergy Therapeutics Sales (M USD), Revenue (US$ Million), Price () and Gross Margin (2019-2024)
Table 119. Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
Table 120. Intrommune Therapeutics Recent Development
Table 121. North America Peanut Allergy Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 122. North America Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024) & (US$ Million)
Table 123. North America Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 124. North America Peanut Allergy Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 125. North America Peanut Allergy Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 126. Europe Peanut Allergy Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 127. Europe Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024) & (US$ Million)
Table 128. Europe Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 129. Europe Peanut Allergy Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 130. Europe Peanut Allergy Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 131. China Peanut Allergy Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 132. China Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024) & (US$ Million)
Table 133. Asia Peanut Allergy Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 134. Asia Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024) & (US$ Million)
Table 135. Asia Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. Asia Peanut Allergy Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 137. Asia Peanut Allergy Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 138. MEALA Peanut Allergy Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 139. MEALA Peanut Allergy Therapeutics Revenue by Distribution Channel (2019-2024) & (US$ Million)
Table 140. MEALA Peanut Allergy Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 141. MEALA Peanut Allergy Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 142. MEALA Peanut Allergy Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 143. Research Programs/Design for This Report
Table 144. Authors List of This Report
Table 145. Secondary Sources
Table 146. Primary Sources
List of Figures
Figure 1. Peanut Allergy Therapeutics Product Picture
Figure 2. Global Peanut Allergy Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Peanut Allergy Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Epinephrine Injection Picture
Figure 5. Antihistamines Picture
Figure 6. Oral Immunotherapy Picture
Figure 7. Other Picture
Figure 8. Global Peanut Allergy Therapeutics Market Size Growth Rate by Distribution Channel (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Peanut Allergy Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 10. Hospital Pharmacy Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Other Picture
Figure 13. Global Peanut Allergy Therapeutics Market Size (US$ Million) & (2019-2030)
Figure 14. Global Peanut Allergy Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Peanut Allergy Therapeutics Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Peanut Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Peanut Allergy Therapeutics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Peanut Allergy Therapeutics Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2019-2030)
Figure 21. Global Peanut Allergy Therapeutics Revenue by Distribution Channel (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2019 VS 2023 VS 2030)
Figure 23. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2019-2030)
Figure 24. North America Peanut Allergy Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Peanut Allergy Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
Figure 27. North America Peanut Allergy Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Peanut Allergy Therapeutics Revenue Share by Application (2019-2030)
Figure 29. North America Peanut Allergy Therapeutics Revenue Share by Country (2019-2030)
Figure 30. United States Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Peanut Allergy Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Peanut Allergy Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
Figure 35. Europe Peanut Allergy Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Peanut Allergy Therapeutics Revenue Share by Application (2019-2030)
Figure 37. Europe Peanut Allergy Therapeutics Revenue Share by Country (2019-2030)
Figure 38. Germany Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Peanut Allergy Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Peanut Allergy Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
Figure 47. China Peanut Allergy Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Peanut Allergy Therapeutics Revenue Share by Application (2019-2030)
Figure 49. Asia Peanut Allergy Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Peanut Allergy Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
Figure 52. Asia Peanut Allergy Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Peanut Allergy Therapeutics Revenue Share by Application (2019-2030)
Figure 54. Asia Peanut Allergy Therapeutics Revenue Share by Country (2019-2030)
Figure 55. Japan Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Peanut Allergy Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Peanut Allergy Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Peanut Allergy Therapeutics Revenue Share by Type (2019-2030)
Figure 64. MEALA Peanut Allergy Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Peanut Allergy Therapeutics Revenue Share by Application (2019-2030)
Figure 66. MEALA Peanut Allergy Therapeutics Revenue Share by Country (2019-2030)
Figure 67. Mexico Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Peanut Allergy Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
